全文获取类型
收费全文 | 195391篇 |
免费 | 2348篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 1323篇 |
儿科学 | 7357篇 |
妇产科学 | 3619篇 |
基础医学 | 18976篇 |
口腔科学 | 1738篇 |
临床医学 | 16254篇 |
内科学 | 34127篇 |
皮肤病学 | 1007篇 |
神经病学 | 18090篇 |
特种医学 | 9236篇 |
外科学 | 30602篇 |
综合类 | 2511篇 |
一般理论 | 34篇 |
预防医学 | 20717篇 |
眼科学 | 2918篇 |
药学 | 10882篇 |
2篇 | |
中国医学 | 630篇 |
肿瘤学 | 17748篇 |
出版年
2023年 | 122篇 |
2022年 | 165篇 |
2021年 | 457篇 |
2020年 | 306篇 |
2019年 | 469篇 |
2018年 | 22377篇 |
2017年 | 17737篇 |
2016年 | 19894篇 |
2015年 | 1401篇 |
2014年 | 1449篇 |
2013年 | 1750篇 |
2012年 | 8429篇 |
2011年 | 22403篇 |
2010年 | 19565篇 |
2009年 | 12212篇 |
2008年 | 20774篇 |
2007年 | 23092篇 |
2006年 | 1982篇 |
2005年 | 3502篇 |
2004年 | 4680篇 |
2003年 | 5543篇 |
2002年 | 3613篇 |
2001年 | 449篇 |
2000年 | 544篇 |
1999年 | 346篇 |
1998年 | 438篇 |
1997年 | 402篇 |
1996年 | 280篇 |
1995年 | 264篇 |
1994年 | 265篇 |
1993年 | 183篇 |
1992年 | 152篇 |
1991年 | 193篇 |
1990年 | 233篇 |
1989年 | 165篇 |
1988年 | 154篇 |
1987年 | 122篇 |
1986年 | 125篇 |
1985年 | 112篇 |
1984年 | 98篇 |
1983年 | 79篇 |
1982年 | 103篇 |
1981年 | 92篇 |
1980年 | 116篇 |
1979年 | 49篇 |
1978年 | 69篇 |
1976年 | 49篇 |
1974年 | 58篇 |
1938年 | 60篇 |
1932年 | 57篇 |
排序方式: 共有10000条查询结果,搜索用时 656 毫秒
61.
Denis Nissim-Sabat William H. Farr Kathleen McCune Melanie Stith 《Community mental health journal》1986,22(2):160-165
This study represents the first of a two-stage project. The first phase of the study examined the funding sources for the 40 Community Services Boards in Virginia. Data provided from the Department of Mental Health and Mental Retardation in Virginia examined fee collections which are comprised of direct client, commercial insurance, Medicaid and Medicare. An analysis of quarterly reports from 1982 to 1984 revealed that Medicaid collections have decreased significantly, while commercial insurance reimbursements have increased significantly. These results, although limited to data from Virginia, point to the need to examine if these shifts are occurring nation-wide, and to determine if the shift toward commercial insurance is impacting upon the delivery of services in Community Mental Health Centers. 相似文献
62.
Williamson Kathleen A.; Hever Ann M.; Rainger Joe; Rogers R. Curtis; Magee Alex; Fiedler Zdenek; Keng Wee Teik; Sharkey Freddie H.; McGill Niolette; Hill Clare J.; Schneider Adele; Messina Mario; Turnpenny Peter D.; Fantes Judy A.; van Heyningen Veronica; FitzPatrick David R. 《Human molecular genetics》2006,15(12):2030
Table 1 相似文献
63.
Edward M Messing Judith Manola George Wilding Kathleen Propert Jonathan Fleischmann E David Crawford J Edson Pontes Richard Hahn Donald Trump 《Journal of clinical oncology》2003,21(7):1214-1222
PURPOSE: To evaluate the role of adjuvant interferon alfa after complete resection of locally extensive renal cell carcinoma. PATIENTS AND METHODS: A total of 283 eligible patients with pT3-4a and/or node-positive disease were randomly assigned after radical nephrectomy and lymphadenectomy to observation or to interferon alfa-NL (Wellferon, Burroughs-Wellcome, Research Park, NC) given daily for 5 days every 3 weeks for up to 12 cycles. Patients were stratified on the basis of pathologic stage. Patients remained on treatment until documented recurrence, excessive toxicity, or patient/physician preference deemed removal appropriate. RESULTS: At median follow-up of 10.4 years, median survival was 7.4 years in the observation arm and 5.1 year in the treatment arm (log-rank P =.09). Median recurrence-free survival was 3.0 years in the observation arm and 2.2 years in the interferon arm (P =.33). Performance status (P =.003), nodal status (N2 v N0, P <.0001), and tumor stage (P =.0002) were significant prognostic factors in multivariate analysis. A proportional hazards model examining the effects of treatment arm and time to recurrence on survival after recurrence among patients who recurred found that random assignment to interferon treatment (P =.009) and shorter time to recurrence (P <.0001) were independent predictors of shorter survival after recurrence. Although no lethal toxicities were observed, severe (grade 4) toxicities including neutropenia, myalgia, fatigue, depression, and other neurologic toxicities occurred in 11.4% of those randomly assigned to interferon treatment. CONCLUSION: Adjuvant treatment with interferon did not contribute to survival or relapse-free survival in this group of patients. 相似文献
64.
65.
Sergio Barroilhet Adrián Cano-Prous Salvador Cervera-Enguix Maria João Forjaz Francisco Guillén-Grima 《Social psychiatry and psychiatric epidemiology》2009,44(12):1051-1065
Introduction
This paper presents the results of a study on the psychometric properties of an authorized Spanish version of the McMaster Family Assessment Device, a self-report measure of family functioning. 相似文献66.
67.
Kathleen Hawker 《Annals of Indian Academy of Neurology》2009,12(4):221-225
B cells have recently been identified as an integral component of the immune system; they play a part in autoimmunity through antigen presentation, antibody secretion, and complement activation. Animal models of multiple sclerosis (MS) suggest that myelin destruction is partly mediated through B cell activation (and plasmablasts). MS patients with evidence of B cell involvement, as compared to those without, tend to have a worse prognosis. Finally, the significant decrease in new gadolinium-enhancing lesions, new T2 lesions, and relapses in MS patients treated with rituximab (a monoclonal antibody against CD20 on B cells) leads us to the conclusion that B cells play an important role in MS and that immune modulation of these cells may ameliorate the disease. This article will explore the role of B cells in MS and the rationale for the development of B cell–targeted therapeutics. MS is an immune-mediated disease that affects over 2 million people worldwide and is the number one cause of disability in young patients. Most therapeutic targets have focused on T cells; however, recently, the focus has shifted to the role of B cells in the pathogenesis of MS and the potential of B cells as a therapeutic target. 相似文献
68.
69.
Introduction
Although ependymoma is the third most common pediatric brain tumor, we know little about the genetic/epigenetic basis of its initiation, maintenance, or progression. This is due in part to the heterogeneity of the disease, as well as the small sample size of the cohorts analyzed in most studies. 相似文献70.
Peter Angelos 《World journal of surgery》2009,33(4):609-611